Orgenesis Inc. (ORGS)
Data as of , from SEC Form 4 filings.
See up to 3 months of ORGS. The 7-day demo opens the 1M and 3M ranges and puts ORGS on your watchlist.
Start 7-day demoLatest ORGS insider trades
About Orgenesis Inc. (ORGS)
The SEC lists Orgenesis Inc. under CIK 0001460602, in pharmaceutical preparations. It is grouped with Health Care companies on this site.
ORGS Form 4 activity by transaction type, last 90 days
No Form 4 activity for ORGS in the last 90 days.
ORGS insider transactions (Form 4)
187 Form 4 filings on record, the earliest from Dec 4, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Adam Pelavin - Director | Grant or award | Stock Option | 625 | $0.00 | - | |
| Adam Pelavin - Director | Grant or award | Stock Option | 1,250 | $0.00 | - | |
| Santhosh Nagaraj - Director | Grant or award | Stock Option | 625 | $0.00 | - | |
| Santhosh Nagaraj - Director | Grant or award | Stock Option | 1,250 | $0.00 | - | |
| Itzhak Vider - Director | Grant or award | Stock Option | 1,500 | $0.00 | - | |
| Jagannathan Bhalaji - Director | Grant or award | Stock Option | 625 | $0.00 | - | |
| Jagannathan Bhalaji - Director | Grant or award | Stock Option | 1,250 | $0.00 | - | |
| Ashish Nanda - Director | Grant or award | Stock Option | 1,835 | $0.00 | - | |
| Yaron Adler - Director | Grant or award | Stock Option | 1,750 | $0.00 | - | |
| Jacob Safier - 10% Owner | Open-market purchase | Common Stock | 10,000 | $0.59 | $6K | |
| Jacob Safier - 10% Owner | Open-market sale | Common Stock | 10,000 | $0.54 | $5K | |
| Jacob Safier - 10% Owner | Open-market purchase | Common Stock | 10,000 | $0.51 | $5K | |
| Jacob Safier - 10% Owner | Open-market sale | Common Stock | 10,000 | $0.50 | $5K | |
| Jacob Safier - 10% Owner | Open-market purchase | Common Stock | 10,000 | $0.58 | $6K | |
| Jacob Safier - 10% Owner | Open-market sale | Common Stock | 10,000 | $0.58 | $6K | |
| Jacob Safier - 10% Owner | Grant or award | Warrant (right to buy) | 970,873 | $0.00 | - | |
| Jacob Safier - 10% Owner | Grant or award | Warrant (right to buy) | 242,718 | $0.00 | - | |
| Jacob Safier - 10% Owner | Grant or award | Warrant (right to buy) | 242,718 | $0.00 | - |
ORGS insider trading FAQ
What is the latest insider trade for ORGS?
Orgenesis Inc. (ORGS) has filed no insider reports in the last 90 days. The most recent on record is dated 2024-12-16. The full record for ORGS runs to 7 Form 4 filings, the earliest from 2024-12-04. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ORGS stock?
No insider purchases of ORGS were filed in the last 90 days. 3 purchases are on record for this company.
How many insiders are selling ORGS stock?
No insider sales of ORGS were filed in the last 90 days. 3 sales are on record for this company.
Where can I see ORGS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ORGS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
7The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Adam Pelavin view on EDGAR
- - Santhosh Nagaraj view on EDGAR
- - Itzhak Vider view on EDGAR
- - Jagannathan Bhalaji view on EDGAR
- - Ashish Nanda view on EDGAR
- - Yaron Adler view on EDGAR
- - Jacob Safier view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where ORGS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ORGS with a 7-day demo
- ORGS on your watchlist
- Every ORGS Form 4 filing on record
- Up to 3 months of ORGS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
